Zevra Therapeutics, Inc.

ZVRA · NASDAQ
Analyze with AI
$8.12−$0.05 (−0.61%)
At close:Dec 16, 2025, 9:00 PM UTC
$8.12+$0.00 (+0%)
After hours:Dec 17, 2025, 1:18 PM UTC
P/E TTM168.24
P/B TTM3.79
P/S TTM7.37
Dividend Yield0%
EPS$0.46
Beta1.011
Valuation
PEG Ratio1.73
FCF Yield-10.18%
EV / EBITDA-4.10
More On Valuation »
Quality
ROIC-12.23%
Gross Margin71.96%
Cash Conv. Ratio-17.48
More On Quality »
Growth
Revenue 3Y CAGR32.45%
FCF Growth-105.92%
More On Growth »
Safety
Net Debt / EBITDA-0.13
Interest Coverage-16.02
More On Safety »
Efficiency
Inventory Turnover15.70
Cash Conv. Cycle-201.70
More On Efficiency »

Zevra Therapeutics, Inc. (ZVRA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Zevra Therapeutics, Inc. (ZVRA) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Zevra Therapeutics, Inc. (ZVRA) stock is trading at $8.12. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ZVRA stock quotes for informed trading decisions.

What is Zevra Therapeutics, Inc.'s market capitalization?

Zevra Therapeutics, Inc. (ZVRA) has a market capitalization of approximately $457.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Zevra Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the ZVRA stock price changes.

What is the 52-week range for Zevra Therapeutics, Inc. stock?

Zevra Therapeutics, Inc. (ZVRA) stock has traded in a 52-week range of $6.19 — $13.16. The 52-week range shows the highest and lowest prices at which ZVRA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Zevra Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Zevra Therapeutics, Inc. stock have?

Zevra Therapeutics, Inc. (ZVRA) stock recently traded approximately 734.7K shares. Trading volume indicates market liquidity and investor interest in ZVRA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Zevra Therapeutics, Inc. stock.

Does Zevra Therapeutics, Inc. pay dividends to shareholders?

Yes, Zevra Therapeutics, Inc. (ZVRA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Zevra Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Zevra Therapeutics, Inc.'s intraday price range?

Today, Zevra Therapeutics, Inc. (ZVRA) stock has traded in a range of $8.05 — $8.28. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ZVRA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Zevra Therapeutics, Inc. stock data?

AlphaPilot sources real-time ZVRA stock quotes, fundamental financial data, and historical price charts for Zevra Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Zevra Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ZVRA stock performance.